Navigation Links
AMDL Announces Preliminary Third Quarter Earnings; Revises 2008 Guidance
Date:11/12/2008

d important part of our marketing strategy to increase sales revenue; bolster AMDL's competitive position in China and new markets and to drive long-term growth for the Company & our shareholders."

AMDL will discuss its business outlook during its regular quarterly conference call which is scheduled for the end of November. Specific details will be announced later this month.

Mr. MacLellan continued, "With the recent adjustments made in our business -- including an expanded and strengthened senior management team and board of directors, revised business strategy, and prioritized focus on securing additional capital to support AMDL's future growth -- we have embarked on the most exciting era in the Company's history. What lies ahead is the perfect opportunity to establish AMDL as a market-winning leader that delivers lucrative, long-term returns for our employees, partners, customers and shareholders."

Mr. MacLellan will cover today's news in a scheduled presentation he will deliver at Rodman & Renshaw's Annual Global Investment Conference taking place today, November 12th, 2008 at the New York Palace Hotel in New York City. Additionally, interested parties can download a copy of Mr. MacLellan's presentation through the AMDL corporate website located http://www.amdl.com under the "news" section. For additional information please contact Kristine Szarkowitz, SVP, AMDL Investor Relations at 206-310-5323 or kszarkowitz@amdl.com.

About AMDL:

Headquartered in Tustin, CA with operations in Shenzhen, Jiangxi, and Jilin, China, AMDL, Inc., along with its subsidiary Jade Pharmaceutical Inc. (JPI), is a vertically integrated bio-pharmaceutical company devoted to the research, development, manufacturing, and marketing of diagnostic, pharmaceutical, nutritional supplement, and cosmetic products. The company employs over 490 people in the U.S. and China. '/>"/>

SOURCE AMDL, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Metabolex Announces Positive Results From Phase 1a Clinical Trial of MBX-2982
2. Standard & Poors Announces Changes to U.S. Indices
3. Quanterix Corporation Announces the Addition of Dr. Robert Corn to its Scientific Advisory Board
4. Cardiums InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries
5. Tianyin Pharmaceutical Co., Inc. Announces First Quarter 2009 Financial Results
6. China Biologic Products Announces Third Quarter 2008 Results Conference Call
7. Synvista Therapeutics Announces Data Further Demonstrating the Value of Haptoglobin Genotyping in Diabetic Patients During AHA Meeting
8. Heritage Labs Announces A1c Test Certification Milestone
9. Nventa Biopharmaceuticals Announces Third Quarter 2008 Financial Results and Recent Corporate Highlights
10. The Binding Site Announces Trading Update for Year Ended September 30th 2008
11. CorMatrix Announces Pre-Clinical Data Suggesting Next Generation ECM Technology(TM) Can Improve Cardiac Function
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... Nasseo, Inc. today announces that it has been ... of applicants by the Arizona Commerce Authority (ACA) ... The Arizona Innovation Challenge (AIC) awards the most money ... a financial award to what it deems to be ... the art dental and orthopedic implant surface modification technology ...
(Date:6/18/2013)... June 18, 2013 ... research firm, announces the initiation of full ... biopharmaceutical company developing and marketing products for ...      (Logo: http://photos.prnewswire.com/prnh/20130417/608168) ... examining the investment merits of BioAlliance Pharma, ...
(Date:6/18/2013)... MINNEAPOLIS , June 18, 2013  Techne ... today that it has agreed to acquire 100% ... subsidiary Bionostics, Inc. (Bionostics).  Bionostics is a global ... control solutions that verify the proper operation of ... utilized in point of care blood glucose and ...
(Date:6/18/2013)... THE WOODLANDS, Texas , June 18, 2013 ... LXRX ), a biopharmaceutical company focused on ... that John Northcott has joined the ... strategy, and operations. Mr. Northcott brings extensive commercial ... on-market commercialization across a variety of therapeutic areas. ...
Breaking Biology Technology:Nasseo Named 2013 Innovation Challenge Winner by Arizona Commerce Authority 2Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 2Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 3Techne Corporation Announces Acquisition Agreement 2Techne Corporation Announces Acquisition Agreement 3Techne Corporation Announces Acquisition Agreement 4Techne Corporation Announces Acquisition Agreement 5John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations 2John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations 3
... subsidiary obtains $74 million term loanST. LOUIS, May 6 2009 First Quarter ... Net sales decreased to $339 million from $517 million in the first ... EBITDA decreased to $56 million from $95 million in the first quarter of 2008 ... report improved Adjusted EBITDA margins , ...
... First Quarter Financial Results Conference Call and Webcast -CHICAGO, ... today that its common stock is eligible for quotation ... the trading symbol "ADLS." The Company also announced today ... discussing the Company,s 2009 first quarter results on Tuesday, ...
... Technology experts from over 20 countries are in ... environment, topics of global importance and immediacy. The ... forum to discuss initiatives in micromachining and nano ... economic and social outcomes. , The Summit promotes ...
Cached Biology Technology:Solutia Reports First Quarter 2009 Results 2Solutia Reports First Quarter 2009 Results 3Solutia Reports First Quarter 2009 Results 4Solutia Reports First Quarter 2009 Results 5Solutia Reports First Quarter 2009 Results 6Solutia Reports First Quarter 2009 Results 7Solutia Reports First Quarter 2009 Results 8Solutia Reports First Quarter 2009 Results 9Solutia Reports First Quarter 2009 Results 10Solutia Reports First Quarter 2009 Results 11Solutia Reports First Quarter 2009 Results 12Solutia Reports First Quarter 2009 Results 13Solutia Reports First Quarter 2009 Results 14Solutia Reports First Quarter 2009 Results 15Solutia Reports First Quarter 2009 Results 16Solutia Reports First Quarter 2009 Results 17Solutia Reports First Quarter 2009 Results 18Solutia Reports First Quarter 2009 Results 19Solutia Reports First Quarter 2009 Results 20Solutia Reports First Quarter 2009 Results 21Advanced Life Sciences Common Stock Begins Trading on OTC Bulletin Board 2World Micromachine Summit highlights technologies impacting energy and the environment 2
(Date:6/17/2013)... fungi, bacteria, and algae, is a common component of ... in the medical field it,s approved by the ... and used during surgery as a substance that opens ... drugs. , Now Profs. Ehud Gazit and Daniel Segal ... Biotechnology and the Sagol School of Neuroscience, along with ...
(Date:6/17/2013)... 2013) The AGA Research Foundation and Horizon Pharma ... of gastroenterology with the 2013 AGA-Horizon Pharma Fellow Abstract ... , "In its third year, this competition continues to ... on promising careers in basic and clinical research," said ... Research Foundation. "We are extremely proud of all that ...
(Date:6/17/2013)... CORVALLIS, Ore. Amphibian populations are declining worldwide and ... be spread by bullfrogs, but a two-year study shows ... suggestions that bullfrogs are a tolerant carrier host that ... frogs from eggs in controlled experimental conditions, they found ... dendrobatidis , also called Bd or a chytrid fungus, ...
Breaking Biology News(10 mins):Artificial sweetener a potential treatment for Parkinson's disease 2Horizon Pharma Abstract Prizes recognize promising fellows and students 2Bullfrogs may help spread deadly amphibian fungus, but also die from it 2
... Duchenne muscular dystrophy (DMD) tend to manage well through ... early adulthood, or why elderly people who lose muscle ... to regain. Now, researchers at the National Institute of ... the National Institutes of Health, are beginning to find ...
... Palo Alto, CABrazilians are world leaders in using biofuels ... consumption comes from sugarcane, which significantly reduces carbon dioxide ... Now scientists from the Carnegie Institution,s Department of Global ... Expansion of the crop in areas previously occupied by ...
... Michael Croft, Ph.D., a researcher at the La ... molecule,s previously unknown role as a major trigger for ... a promising therapeutic target for chronic asthma, chronic obstructive ... A scientific paper on Dr. Croft,s finding was published ...
Cached Biology News:NIH scientists identify gene that could hold the key to muscle repair 2Sugarcane cools climate 2La Jolla Institute identifies new therapeutic target for asthma, COPD and other lung disorders 2La Jolla Institute identifies new therapeutic target for asthma, COPD and other lung disorders 3
... TempliPhi 500 Amplification Kit, 500 reactions. ... sequencing in 4-6 h.Generate microgram quantities ... of starting material.Use amplified DNA directly ... from bacterial or M13 liquid cultures, ...
For quantitative determination of Aldolase in Serum (an indicator of muscle damage). Ready-to-use liquid stable reagent. Formulated to eliminate interference from pyruvates. Application sheets are ...
Autoclavable, variable volumefitted w./ an anti-drip safety valve; borosilicate glass barrelprotected with transparentpolypropylene sleeve; spring-lock cursor design ensuresfine adjustment for exact ...
Antibodies were affinity purified using epitopes specific to RFC1 immobilized on solid support....
Biology Products: